title: 45 years later...where do we stand?
authors.affiliation: The Thalidomide Victims Association of Canada, Montreal, Canada. mercedes.ocvt@bellnet.ca
authors.forename: Mercédes
authors.initials: M
authors.lastname: Benegbi
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D002170:Canada; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005544:Forecasting; D006266:Health Education / Q000458:organization & administration*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010601:Pharmacology, Clinical / Q000592:standards / Q000639:trends*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D018570:Risk Assessment; D013723:Teratogens / Q000633:toxicity; D013792:Thalidomide / Q000009:adverse effects; D013997:Time Factors
chemical_list: D004364:Pharmaceutical Preparations; D013723:Teratogens; D013792:Thalidomide